312 related articles for article (PubMed ID: 7755911)
1. Protection of neonatal kittens against feline immunodeficiency virus infection with passive maternal antiviral antibodies.
Pu R; Okada S; Little ER; Xu B; Stoffs WV; Yamamoto JK
AIDS; 1995 Mar; 9(3):235-42. PubMed ID: 7755911
[TBL] [Abstract][Full Text] [Related]
2. Effects of passive transfer of immunity on results of diagnostic tests for antibodies against feline immunodeficiency virus in kittens born to vaccinated queens.
MacDonald K; Levy JK; Tucker SJ; Crawford PC
J Am Vet Med Assoc; 2004 Nov; 225(10):1554-7. PubMed ID: 15568387
[TBL] [Abstract][Full Text] [Related]
3. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
[TBL] [Abstract][Full Text] [Related]
4. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
[TBL] [Abstract][Full Text] [Related]
5. Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge.
Huang C; Conlee D; Gill M; Chu HJ
J Feline Med Surg; 2010 Jun; 12(6):451-7. PubMed ID: 20167521
[TBL] [Abstract][Full Text] [Related]
6. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
Kusuhara H; Hohdatsu T; Okumura M; Sato K; Suzuki Y; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
Vet Microbiol; 2005 Jul; 108(3-4):155-65. PubMed ID: 15899558
[TBL] [Abstract][Full Text] [Related]
7. The feline immunodeficiency virus-infected cat: a model for lentivirus-induced placental immunopathology and reproductive failure (mini-review).
Coats KS
Am J Reprod Immunol; 2005 Oct; 54(4):169-85. PubMed ID: 16135008
[TBL] [Abstract][Full Text] [Related]
8. Mechanism(s) of FIV vaccine protection.
Pu R; Tellier MC; Yamamoto JK
Leukemia; 1997 Apr; 11 Suppl 3():98-101. PubMed ID: 9209311
[TBL] [Abstract][Full Text] [Related]
9. Feline immunodeficiency virus vaccine: implications for diagnostic testing and disease management.
Richards JR
Biologicals; 2005 Dec; 33(4):215-7. PubMed ID: 16257536
[TBL] [Abstract][Full Text] [Related]
10. MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors.
Pu R; Omori M; Okada S; Rine SL; Lewis BA; Lipton E; Yamamoto JK
Cell Immunol; 1999 Nov; 198(1):30-43. PubMed ID: 10612649
[TBL] [Abstract][Full Text] [Related]
11. Infection of cats by injection with DNA of a feline immunodeficiency virus molecular clone.
Sparger EE; Louie H; Ziomeck AM; Luciw PA
Virology; 1997 Nov; 238(1):157-60. PubMed ID: 9375019
[TBL] [Abstract][Full Text] [Related]
12. IgG from acutely infected cats blocks mucosal feline immunodeficiency virus infection.
Burkhard MJ; Hoover EA
Vet Immunol Immunopathol; 2005 Jun; 106(1-2):87-95. PubMed ID: 15910995
[TBL] [Abstract][Full Text] [Related]
13. No evidence of vertical transmission of naturally acquired feline immunodeficiency virus infection.
Ueland K; Nesse LL
Vet Immunol Immunopathol; 1992 Sep; 33(4):301-8. PubMed ID: 1332250
[TBL] [Abstract][Full Text] [Related]
14. Shedding of feline immunodeficiency virus in semen of domestic cats during acute infection.
Jordan HL; Liang Y; Hudson LC; Tompkins WA
Am J Vet Res; 1999 Feb; 60(2):211-5. PubMed ID: 10048554
[TBL] [Abstract][Full Text] [Related]
15. Placental immunopathology and pregnancy failure in the FIV-infected cat.
Weaver CC; Burgess SC; Nelson PD; Wilkinson M; Ryan PL; Nail CA; Kelly-Quagliana KA; May ML; Reeves RK; Boyle CR; Coats KS
Placenta; 2005; 26(2-3):138-47. PubMed ID: 15708115
[TBL] [Abstract][Full Text] [Related]
16. Transmission of feline immunodeficiency virus (FIV) among cohabiting cats in two cat rescue shelters.
Litster AL
Vet J; 2014 Aug; 201(2):184-8. PubMed ID: 24698667
[TBL] [Abstract][Full Text] [Related]
17. Experimental oncornavirus vaccines in the cat.
Yohn DS; Olsen RG; Schaller JP; Hoover EA; Mathes LE; Heding L; Davis GW
Cancer Res; 1976 Feb; 36(2 pt 2):646-51. PubMed ID: 943234
[TBL] [Abstract][Full Text] [Related]
18. Vaccination against feline viral rhinotracheitis in kittens with maternally derived feline viral rhinotracheitis antibodies.
Johnson RP; Povey RC
J Am Vet Med Assoc; 1985 Jan; 186(2):149-52. PubMed ID: 2982774
[TBL] [Abstract][Full Text] [Related]
19. Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats.
Kusuhara H; Hohdatsu T; Seta T; Nemoto K; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
Vet Microbiol; 2007 Mar; 120(3-4):217-25. PubMed ID: 17141431
[TBL] [Abstract][Full Text] [Related]
20. [Vaccination of cats against infection with feline leukemia virus (FeLV): first recombinant vaccine and the effect of a pre-existing infection with feline immunodeficiency virus (FIV)].
Hofmann-Lehmann R; Aubert A; Wolfensberger C; Cronier J; Lutz H
Schweiz Arch Tierheilkd; 1994; 136(10):340-51. PubMed ID: 7801087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
